US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jan 21, 2026 (7 months ago)

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

What was recalled

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01

Recalling firm
Unichem Pharmaceuticals USA Inc.
NDC code
29300-187-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0301-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other East recalls

See all